273 related articles for article (PubMed ID: 31071193)
1. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.
Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J
PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193
[TBL] [Abstract][Full Text] [Related]
2. The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate.
Nishimura Y; McLaughlin NP; Pan J; Goldstein S; Hafenstein S; Shimizu H; Winkler JD; Bergelson JM
PLoS Pathog; 2015 Oct; 11(10):e1005184. PubMed ID: 26430888
[TBL] [Abstract][Full Text] [Related]
3. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Dicaffeoylquinic Acid from the Medicinal Plant
Hsieh CF; Chen YL; Lin GH; Chan YF; Hsieh PW; Horng JT
J Virol; 2022 Apr; 96(7):e0054221. PubMed ID: 35319229
[TBL] [Abstract][Full Text] [Related]
5. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence.
Sun L; Tijsma A; Mirabelli C; Baggen J; Wahedi M; Franco D; De Palma A; Leyssen P; Verbeken E; van Kuppeveld FJM; Neyts J; Thibaut HJ
Emerg Microbes Infect; 2019; 8(1):1076-1085. PubMed ID: 31339457
[TBL] [Abstract][Full Text] [Related]
6. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction.
Tan CW; Sam IC; Lee VS; Wong HV; Chan YF
Virology; 2017 Jan; 501():79-87. PubMed ID: 27875780
[TBL] [Abstract][Full Text] [Related]
7. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid.
Martínez-Gualda B; Sun L; Rivero-Buceta E; Flores A; Quesada E; Balzarini J; Noppen S; Liekens S; Schols D; Neyts J; Leyssen P; Mirabelli C; Camarasa MJ; San-Félix A
Antiviral Res; 2017 Mar; 139():32-40. PubMed ID: 28017762
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
Ho JY; Chern JH; Hsieh CF; Liu ST; Liu CJ; Wang YS; Kuo TW; Hsu SJ; Yeh TK; Shih SR; Hsieh PW; Chiu CH; Horng JT
J Antimicrob Chemother; 2016 Jul; 71(7):1922-32. PubMed ID: 27098012
[TBL] [Abstract][Full Text] [Related]
10. Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication.
Helgers LC; Bhoekhan MS; Pajkrt D; Wolthers KC; Geijtenbeek TBH; Sridhar A
Microbiol Spectr; 2022 Dec; 10(6):e0282222. PubMed ID: 36222686
[TBL] [Abstract][Full Text] [Related]
11. Cellular receptors for enterovirus A71.
Kobayashi K; Koike S
J Biomed Sci; 2020 Jan; 27(1):23. PubMed ID: 31924205
[TBL] [Abstract][Full Text] [Related]
12. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
[TBL] [Abstract][Full Text] [Related]
13. Effects and mechanism of Aβ
Zhong M; Wang H; Yan H; Wu S; Wang K; Yang L; Cui B; Wu M; Li Y
Virol J; 2022 Sep; 19(1):151. PubMed ID: 36127711
[TBL] [Abstract][Full Text] [Related]
14. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
[TBL] [Abstract][Full Text] [Related]
15. A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.
Ma C; Hu Y; Zhang J; Musharrafieh R; Wang J
ACS Infect Dis; 2019 Nov; 5(11):1952-1962. PubMed ID: 31532189
[TBL] [Abstract][Full Text] [Related]
16. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ
Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509
[TBL] [Abstract][Full Text] [Related]
17. EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors.
Hu K; Onintsoa Diarimalala R; Yao C; Li H; Wei Y
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992493
[TBL] [Abstract][Full Text] [Related]
18. Assessing
Lanko K; Shi C; Patil S; Delang L; Matthijnssens J; Mirabelli C; Neyts J
ACS Infect Dis; 2021 Oct; 7(10):2801-2806. PubMed ID: 34529400
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
20. Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71).
Lalani S; Masomian M; Poh CL
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]